Adalton Ribeiro1, Silvana Lima1, Maria-Elisa Zampieri1, Mirtes Peinado2, Albert Figueras3,4. 1. a Núcleo de Farmacovigilância , Centro de Vigilância Sanitária de São Paulo , São Paulo , Brazil. 2. b Núcleo Técnico de Planejamento e Informação , Centro de Vigilância Sanitária de São Paulo , São Paulo , Brazil. 3. c Fundació Institut Català de Farmacologia , Barcelona , Spain. 4. d Departament de Farmacologia, de Terapèutica i de Toxicologia , Universitat Autònoma de Barcelona , Barcelona , Spain.
Abstract
BACKGROUND: The completeness and accuracy of the reports of suspected adverse drug reactions is important in pharmacovigilance. The aim of the present study was to analyze the quality of the information included in the reports sent to the Pharmacovigilance Centre of São Paulo (Brazil). RESEARCH DESIGN AND METHODS: A sample of 999 reports received from January 2013 to December 2014 was selected. The quality of the filled information was evaluated according to a 'sufficiency' criterion to apply the Karch-Lasagna causality algorithm. RESULTS: There were 820 reports from manufacturers and 179 from health centres. Only 4.4% (44) were fully filled, thus allowing the adequate analysis of the causal relationship between the suspected medication and the adverse event. In 30% of the reports from manufacturers, the information about the critical variables was lacking or incomplete, preventing the adequate evaluation of the report. It was also noted that the reports' poor filling quality was not related with less severity or with old and well-known medicines. CONCLUSIONS: The poor quality of the information included in the reports received by this centre, especially those sent by pharmaceutical manufacturers, hampers the identification of potential safety signals. Measures to improve the quality of the reports must be urgently adopted.
BACKGROUND: The completeness and accuracy of the reports of suspected adverse drug reactions is important in pharmacovigilance. The aim of the present study was to analyze the quality of the information included in the reports sent to the Pharmacovigilance Centre of São Paulo (Brazil). RESEARCH DESIGN AND METHODS: A sample of 999 reports received from January 2013 to December 2014 was selected. The quality of the filled information was evaluated according to a 'sufficiency' criterion to apply the Karch-Lasagna causality algorithm. RESULTS: There were 820 reports from manufacturers and 179 from health centres. Only 4.4% (44) were fully filled, thus allowing the adequate analysis of the causal relationship between the suspected medication and the adverse event. In 30% of the reports from manufacturers, the information about the critical variables was lacking or incomplete, preventing the adequate evaluation of the report. It was also noted that the reports' poor filling quality was not related with less severity or with old and well-known medicines. CONCLUSIONS: The poor quality of the information included in the reports received by this centre, especially those sent by pharmaceutical manufacturers, hampers the identification of potential safety signals. Measures to improve the quality of the reports must be urgently adopted.
Entities:
Keywords:
Pharmacovigilance; adverse drug reactions; drug safety; quality assessment; reporting; signal detection
Authors: Paulo Henrique Santos Andrade; Amanda Carvalho Barreiros de Almeida; Ana Keilla Santana Dos Santos; Iza Maria Fraga Lobo; Francilene Amaral da Silva; Wellington Barros da Silva Journal: Ther Adv Drug Saf Date: 2020-07-31
Authors: Mário Rui Salvador; Cristina Monteiro; Luísa Pereira; Ana Paula Duarte Journal: Int J Environ Res Public Health Date: 2022-03-22 Impact factor: 3.390
Authors: Ar Kar Aung; Steven Walker; Yin Li Khu; Mei Jie Tang; Jennifer I Lee; Linda Velta Graudins Journal: Eur J Clin Pharmacol Date: 2022-02-16 Impact factor: 2.953